HUM vs MOH
Humana and Molina Healthcare, Inc., both Healthcare
Humana is the larger company at $43B against $10B. Over the past year HUM returned +54% against +31% for MOH. Ryufin's sector-relative Smart Score puts HUM ahead, 6/10 against 3/10.
| Figure | HUM | MOH |
|---|---|---|
| Last close | $391 | $202 |
| Market cap | $43B | $10B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 41.7 | n/a |
| Dividend yield | 0.9% | n/a |
| 1-year return | +54% | +31% |
| 5-year return | -3.7% | -26% |
| Ryufin Smart Scoresector-relative, 1–10 | 6/10 | 3/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Humana
Revenue of $40B in Q1 2026, net income $1.2B. Its largest reported line is Center Well, 85% of the disclosed total.
Molina Healthcare, Inc.
Revenue of $11B in Q2 2026, net income $60M. Its largest reported line is Medicaid, 80% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.